Aileron Therapeutics Inc

NASDAQ:ALRN  
0.44
0.00 (+0.02%)
Earnings Announcements

Aileron Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:55 GMT
Aileron Therapeutics Inc (ALRN) - Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights.
Aileron Therapeutics Inc - Cash Runway Into Q4 of 2023.
Aileron Therapeutics Inc - Basic and Diluted Net Loss per Share for Q1 of 2022 Was $0.09.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.